Evidence for medical cannabis use and effectiveness in autism has begun to accumulate but remains limited, even as clinical interest has rapidly increased. I…
Medicinal cannabis plant extract (NTI164) modifies epigenetic, ribosomal, and immune pathways in paediatric acute-onset neuropsychiatric syndrome.
Paediatric acute-onset neuropsychiatric syndrome (PANS) is a syndrome of infection-provoked abrupt-onset obsessive-compulsive disorder (OCD) or eating restri…
Cannabinoids for Autism: Clinical Evidence Reviewed
Clinical Takeaway CBD-based treatments, particularly cannabidiol-rich preparations, have shown preliminary benefits for certain autism-associated behaviors such as irritability, hyperactivity, and social communication challenges in some clinical trials. However, the current evidence base...
South Carolina Senate passes THC restrictions aimed at keeping products from teens
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyTHCSafetyPediatrics Clinical Summary # Clinical Summary South Carolina's Senate has passed legislation implementing THC content...
Pilot Study Finds Salivary Metabolite Shifts in Autistic Children Treated with Medical Cannabis—But Evidence Remains Preliminary
“Sixty-five potential cannabis-responsive biomarkers exhibiting a shift toward the TD physiological levels were identified in children with ASD after MC treatment.” — Authors’ caution that larger trials are needed is appropriate, but the term ‘Cannabis-Responsive’ implies causation the design cannot support.
Rigorous CBD Trial for Autism Behavioral Symptoms Launches—But Results Are Not Yet In
There is a significant need for clinical research exploring alternative medications for the treatment of behavioral symptoms of ASD. Cannabidiol (CBD) is being studied for the management of irritability, aggression, and other problem behaviors associated with ASD.
Small Pilot Trial Tests Medicinal Cannabis for Teen Tourette Syndrome—Finds Protocol Feasible, Efficacy Questions Remain
The findings suggest that the study protocol is feasible and acceptable to patients with TS and their families. A fully powered study is needed to evaluate the efficacy of MC in adolescent TS.
Analysis: No Rise in Problematic Cannabis Use Among Teens Following Adult-Use Legalization
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyResearchPediatricsSafetyMental Health Why This Matters Clinicians can provide reassurance to patients and families concerned about...
Major autism study tests Melbourne-made cannabis oil on children | Herald Sun
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic AutismPediatricsClinical TrialsCbdNeurodevelopment Why This MattersAutism spectrum disorder affects 1 in 36 children with...
Effects of Cannabidiol on Social Relating, Anxiety, and Parental Stress in Autistic Children
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic AutismPediatricsCbdSocial CommunicationAnxiety Why This MattersThis study addresses a significant clinical gap, as autism spectrum...